Secondary Logo

Use of GLP-1 receptor agonists in patients with T2DM and chronic kidney disease

Diabetes mellitus is the leading cause of chronic kidney disease (CKD) in the US. An increasing number of glucagon-like peptide-1 receptor agonists are available for diabetes management. Differences between medications in this class, as well as limited data on patients with CKD, underscore the importance of a patient-centered approach to care.

Get Content & Permissions

Polycystic ovary syndrome: Diagnosis and management

Polycystic ovary syndrome (PCOS) is a common endocrine disorder. Patients may present with a combination of hyperandrogenism symptoms, menstrual irregularities, metabolic syndrome, infertility, acne, and obesity. PCOS diagnosis is based on three diagnostic guidelines. Treatment options include oral contraceptive pills, antiandrogens, and metformin. NPs can improve diagnosed patients' quality of life through education about this disorder.

Get Content & Permissions

Treating pediatric acute-onset neuropsychiatric syndrome

Pediatric acute-onset neuropsychiatric syndrome (PANS) can be caused by infectious and noninfectious triggers. NPs can help children with PANS recover from their symptoms and prevent future recurrences by appropriately screening, recognizing, and diagnosing the clinical presentation of PANS. PANS treatment includes pharmacologic therapies as well as cognitive behavioral therapy.

Get Content & Permissions

Infection prevention and control core practices: A roadmap for nursing practice

The CDC continues to stress the urgent issue of increasing microbial resistance. The organization recently joined forces with the American Nurses Association to bring awareness to this issue through an approach that prevents inappropriate antibiotic use and stresses infection prevention.

Get Content & Permissions

Quick Poll

There are currently between X and Y number of individuals with familial hypercholesterolemia in the US.
There are currently between X and Y number of individuals with familial hypercholesterolemia in the US.
There are currently between X and Y number of individuals with familial hypercholesterolemia in the US.
There are currently between X and Y number of individuals with familial hypercholesterolemia in the US.
There are currently between X and Y number of individuals with familial hypercholesterolemia in the US.
 Submit
 Clear
 Results